Skip to content

Author

Kazuaki Mori

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide, and galactose-deficient IgA1 (Gd-IgA1) is widely recognized as the central pathogenic molecule in the current multi-hit model of IgAN. Over the past few decades, advances in our understanding of IgAN pathogenesis have driven the dev...

Kazuaki Mori, Y. Nihei, Yusuke Suzuki · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.